Characterizing Intravesical Delivery of Chitosan/Interleukin-12 for the Immunotherapy of Bladder Cancer.

dc.contributor.advisorDavid Zaharoff, Chair
dc.contributor.advisorZhen Gu, Member
dc.contributor.advisorBoyce Griffith, Inter-Institutional
dc.contributor.advisorWilliam Kim, Inter-Institutional
dc.contributor.advisorPaul Hess, Graduate School Representative
dc.contributor.authorSmith, Sean Gregory
dc.date.accepted2017-06-19
dc.date.accessioned2018-07-14T12:32:17Z
dc.date.available2018-07-14T12:32:17Z
dc.date.defense2017-06-01
dc.date.embargo2018-07-14
dc.date.issued2017-06-01
dc.date.released2018-07-14
dc.date.reviewed2017-06-06
dc.date.submitted2017-06-02
dc.degree.disciplineBiomedical Engineering
dc.degree.leveldissertation
dc.degree.nameDoctor of Philosophy
dc.identifier.otherdeg6770
dc.identifier.urihttp://www.lib.ncsu.edu/resolver/1840.20/35394
dc.rights
dc.titleCharacterizing Intravesical Delivery of Chitosan/Interleukin-12 for the Immunotherapy of Bladder Cancer.

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
etd.pdf
Size:
5.17 MB
Format:
Adobe Portable Document Format

Collections